In the present work, we demonstrate that centrosomal protein 290 (CEP290), which regulates cancer cell ferroptosis, growth, migration and invasion through the Nrf2 signaling pathway, is a reliable biomarker for prognosis prediction. Here, CEP290 is linked to cancer.